<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hadland B</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>European Hematology Association</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Heart, Lung, and Blood Institute</funding><funding>American Society of Hematology</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>1584</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8948249</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Hematopoietic stem cells (HSCs) develop from hemogenic endothelium within embryonic arterial vessels such as the aorta of the aorta-gonad-mesonephros region (AGM). To identify the signals responsible for HSC formation, here we use single cell RNA-sequencing to simultaneously analyze the transcriptional profiles of AGM-derived cells transitioning from hemogenic endothelium to HSCs, and AGM-derived endothelial cells which provide signals sufficient to support HSC maturation and self-renewal. Pseudotemporal ordering reveals dynamics of gene expression during the hemogenic endothelium to HSC transition, identifying surface receptors specifically expressed on developing HSCs. Transcriptional profiling of niche endothelial cells identifies corresponding ligands, including those signaling to Notch receptors, VLA-4 integrin, and CXCR4, which, when integrated in an engineered platform, are sufficient to support the generation of engrafting HSCs. These studies provide a transcriptional map of the signaling interactions necessary for the development of HSCs and advance the goal of engineering HSCs for therapeutic applications.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics.</pubmed_title><pmcid>PMC8948249</pmcid><funding_grant_id>NA</funding_grant_id><funding_grant_id>R35 HL150809</funding_grant_id><funding_grant_id>R01DK110563</funding_grant_id><funding_grant_id>K08HL140143</funding_grant_id><funding_grant_id>P30 CA015704</funding_grant_id><funding_grant_id>TRTH153</funding_grant_id><funding_grant_id>RC2DK114777</funding_grant_id><funding_grant_id>R01 DK110563</funding_grant_id><funding_grant_id>RC2 DK114777</funding_grant_id><funding_grant_id>K08 HL140143</funding_grant_id><pubmed_authors>Bernstein ID</pubmed_authors><pubmed_authors>Butler JM</pubmed_authors><pubmed_authors>Nourigat-McKay C</pubmed_authors><pubmed_authors>Ishida T</pubmed_authors><pubmed_authors>Hadland B</pubmed_authors><pubmed_authors>Trapnell C</pubmed_authors><pubmed_authors>Varnum-Finney B</pubmed_authors><pubmed_authors>Dozono S</pubmed_authors><pubmed_authors>Jackson DL</pubmed_authors><pubmed_authors>Itkin T</pubmed_authors><pubmed_authors>Heck AM</pubmed_authors><pubmed_authors>Rafii S</pubmed_authors><pubmed_authors>Dignum T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics.</name><description>Hematopoietic stem cells (HSCs) develop from hemogenic endothelium within embryonic arterial vessels such as the aorta of the aorta-gonad-mesonephros region (AGM). To identify the signals responsible for HSC formation, here we use single cell RNA-sequencing to simultaneously analyze the transcriptional profiles of AGM-derived cells transitioning from hemogenic endothelium to HSCs, and AGM-derived endothelial cells which provide signals sufficient to support HSC maturation and self-renewal. Pseudotemporal ordering reveals dynamics of gene expression during the hemogenic endothelium to HSC transition, identifying surface receptors specifically expressed on developing HSCs. Transcriptional profiling of niche endothelial cells identifies corresponding ligands, including those signaling to Notch receptors, VLA-4 integrin, and CXCR4, which, when integrated in an engineered platform, are sufficient to support the generation of engrafting HSCs. These studies provide a transcriptional map of the signaling interactions necessary for the development of HSCs and advance the goal of engineering HSCs for therapeutic applications.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-09T23:43:39.802Z</modification><creation>2025-04-04T22:14:03.093Z</creation></dates><accession>S-EPMC8948249</accession><cross_references><pubmed>35332125</pubmed><doi>10.1038/s41467-022-28781-z</doi></cross_references></HashMap>